The National Institutes of Health
(NIH) Commercialization Accelerator Program (CAP) has been offered
annually since 2004 (previously known as the Commercialization
Assistance Program), and is designed to help some of the agency’s
most promising small life science and healthcare Phase II awardees
develop their commercial businesses and transition their
SBIR/STTR-funded technologies into the marketplace. Applicants are
selected via a competitive process for a limited number of slots in
the program. Funded by NIH and managed through a contract, the CAP
provides selected participants with individualized assistance
toward accomplishing key commercialization goals. This is achieved
through individual mentoring and consulting sessions, training
workshops, access to domain experts, and focus on outcomes that
will enhance the commercialization profile and readiness of
participating awardees.
US Code:
15
USC 638 Name of Law: Small Business Act
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.